Drug profile · INN
betamethasone sodium phosphate
BETAMETHASONE SODIUM PHOSPHATE
betamethasone sodium phosphate (BETAMETHASONE SODIUM PHOSPHATE) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — betamethasone sodium phosphate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
betamethasone sodium phosphate (BETAMETHASONE SODIUM PHOSPHATE) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is betamethasone sodium phosphate?
betamethasone sodium phosphate (BETAMETHASONE SODIUM PHOSPHATE) is a glucocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for betamethasone sodium phosphate?
BETAMETHASONE SODIUM PHOSPHATE is a marketed brand name for betamethasone sodium phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of betamethasone sodium phosphate?
betamethasone sodium phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.